Phase II Trial of Sunitinib in Patients With Metastatic Colorectal Cancer After Failure of Standard Therapy
SALTZ, Leonard B, ROSEN, Lee S, XIN HUANG, DEPRIMO, Samuel E, CHOW-MANEVAL, Edna, CHAO, Richard C, LENZ, Heinz J, MARSHALL, John L, BELT, Robert J, HURWITZ, Herbert L, ECKHARDT, S. Gail, BERGSLAND, Emily K, HALLER, Daniel G, LOCKHART, A. Craig, ROCHA LIMA, Caio M
Published in Journal of clinical oncology (20.10.2007)
Published in Journal of clinical oncology (20.10.2007)
Get full text
Journal Article
S0356: A Phase II Clinical and Prospective Molecular Trial With Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients With Esophageal Adenocarcinoma
LEICHMAN, Lawrence P, GOLDMAN, Bryan H, DANENBERG, Kathleen D, BLANKE, Charles D, BOHANES, Pierre O, LENZ, Heinz J, THOMAS, Charles R, BILLINGSLEY, Kevin G, CORLESS, Christopher L, IQBAL, Syma, GOLD, Philip J, BENEDETTI, Jacqueline K
Published in Journal of clinical oncology (01.12.2011)
Published in Journal of clinical oncology (01.12.2011)
Get full text
Journal Article
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors
Thomas, Jacob S., El-Khoueiry, Anthony B., Maurer, Barry J., Groshen, Susan, Pinski, Jacek K., Cobos, Everardo, Gandara, David R., Lenz, Heinz J., Kang, Min H., Reynolds, C. Patrick, Newman, Edward M.
Published in Cancer chemotherapy and pharmacology (01.04.2021)
Published in Cancer chemotherapy and pharmacology (01.04.2021)
Get full text
Journal Article
Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial
Luu, Thehang, Frankel, Paul, Beumer, Jan H., Lim, Dean, Cristea, Mihaela, Appleman, Leonard J., Lenz, Heinz J., Gandara, David R., Kiesel, Brian F., Piekarz, Richard L., Newman, Edward M.
Published in Cancer chemotherapy and pharmacology (01.12.2019)
Published in Cancer chemotherapy and pharmacology (01.12.2019)
Get full text
Journal Article
A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine, administered with tetrahydrouridine
Newman, Edward M., Morgan, Robert J., Kummar, Shivaani, Beumer, Jan H., Blanchard, M. Suzette, Ruel, Christopher, El-Khoueiry, Anthony B., Carroll, Mary I., Hou, Jessie M., Li, Chun, Lenz, Heinz J., Eiseman, Julie L., Doroshow, James H.
Published in Cancer chemotherapy and pharmacology (01.03.2015)
Published in Cancer chemotherapy and pharmacology (01.03.2015)
Get full text
Journal Article
Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients
Rubinson, Douglas A., Hochster, Howard S., Ryan, David P., Wolpin, Brian M., McCleary, Nadine Jackson, Abrams, Thomas A., Chan, Jennifer A., Iqbal, Syma, Lenz, Heinz J., Lim, Dean, Rose, Jeffrey, Bekaii-Saab, Tanios, Chen, Helen X., Fuchs, Charles S., Ng, Kimmie
Published in Investigational new drugs (01.02.2014)
Published in Investigational new drugs (01.02.2014)
Get full text
Journal Article
Outcome According to Tumor Ras Mutation Status in Crystal Study Patients with Metastatic Colorectal Cancer Randomized to Folfiri with or Without Cetuximab as First-Line Treatment
Van Cutsem, E., Lenz Heinz, J., Köhne, C.H., Heinemann, V., Tejpar, S., Melezinek, I., Beier, F., Duecker, K., van Krieken, H., Ciardiello, F.
Published in Annals of oncology (01.06.2014)
Published in Annals of oncology (01.06.2014)
Get full text
Journal Article
A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fuoro-2′-deoxycytidine, administered with tetrahydrouridine
Newman, Edward M., Morgan, Robert J., Kummar, Shivaani, Beumer, Jan H., Blanchard, M. Suzette, Ruel, Christopher, El-Khoueiry, Anthony B., Carroll, Mary I., Hou, Jessie M., Li, Chun, Lenz, Heinz J., Eiseman, Julie L., Doroshow, James H.
Published in Cancer chemotherapy and pharmacology (08.01.2015)
Published in Cancer chemotherapy and pharmacology (08.01.2015)
Get full text
Journal Article
Abstract 1283: Phase I and pharmacokinetic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine: A California Cancer Consortium study
Newman, Edward M., Morgan, Robert J., Beumer, Jan H., Blanchard, Suzette M., El-Khoueiry, Anthony B., Kummar, Shivaani, Carroll, Mary I., Synold, Timothy W., Lenz, Heinz J., Doroshow, James H.
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article